RDDT
$91.73 at the check
LONG

Kairon's answer on RDDT: leaning up.

Checked Nov 2, 2026 at $91.73, time frame 2-6 weeks
Why? For, against, what would change it
  • ForThe company has strong growth, with earnings per share up 108.6% and revenue up 53.6% over the past year.
  • AgainstShares outstanding have increased by 21.5% in three years, which dilutes the value of each share.
  • What would change the pictureIf next quarter's revenue growth falls below 10% year-over-year or earnings miss expectations by more than 15%, outlook will worsen.
Result check on Jan 31, 2027: open.

The 10-second check

Loading filings…

Both sides

More for

RDDT is priced at a deep value level for a high-growth company.

The company combines high profitability, excellent returns, robust free cash flow, and extraordinary liquidity.

More against

Severe price dislocation confirms maximum trend breakdown.

Dilution reduces per-share value; insider selling and wide target dispersion signal uncertainty and potential for future further dilution or lower EPS growth.

Read the full debate between the bull and the bear analyst

Bull Analyst: BULL CASE ARGUMENTS

---

Argument 1 – Valuation/Forward Earnings [HIGH conviction]
Evidence: *Forward P/E 9.82x*; *PEG 0.46*. Next-12mo consensus EPS has *risen from 6.54 (90d ago) to 7.11 (+8.7%)*, with *four straight quarterly EPS beats (+33.1%, +79.1%, +29.6%, +5.6%)*.
Thesis: RDDT is priced at a deep value level for a high-growth company. Forward P/E below 10 and PEG well under 1 (<0.5) are rare in growth sectors, suggesting substantial upside if the earnings trajectory persists. Estimate revisions confirm analyst optimism and execution momentum, supporting fundamental re-rating.

---

Argument 2 – Profitability/Balance Sheet [HIGH conviction]
Evidence: *Net margin 32.1%*, *ROE 32%*, *FCF $812M*, *Current ratio 10.8*, *Debt/Equity 0.88*.
Thesis: The company combines high profitability (32% net margin), excellent returns (ROE 32%), robust free cash flow ($812M), and extraordinary liquidity (current ratio 10.8). This profile is top decile for operational and financial quality. Modest leverage (debt/equity <1) reduces solvency risk, which is critical during market volatility.

---

Argument 3 – Growth [HIGH conviction]
Evidence: *EPS growth +108.6% YoY*, *Revenue growth +53.6% YoY*.
Thesis: Growth rates are impressive for a large-cap, especially with EPS more than doubling and revenue up over 50% year-on-year. These are well above typical “high growth” peers, showing both expansion and operational leverage—critical for supporting future valuations.

---

Argument 4 – Mean Reversion Setup [MEDIUM conviction]
Evidence: *RSI 17.45 (deeply oversold)*, *MACD Histogram -5.05 (maximum downward acceleration)*, *Price 42% below 200MA; closed far below lower Bollinger Band ($115.51 vs $91.73) with widened bands*, *Quant mean-reversion signals: bollinger_pos +100, RSI_reversion +95, short_term_reversal +100.*
Thesis: Technical and quant signals indicate maximum oversold conditions after capitulation; probability-weighted mean reversion has an *expected return +4.6% (Monte Carlo)*, with *44.1% chance of >+5% bounce in 21 days* (though left-tail risk remains very high). The risk/reward ratio for a tactical bounce is attractive, but conviction is only medium due to trend conflict.

---

Argument 5 – Estimate Momentum/Catalyst [MEDIUM conviction]
Evidence: *Next-12-mo EPS revision up 8.7% in 90 days*; *analyst average price target $165.8 (+80.8% upside)*, despite wide dispersion and low consensus.
Thesis: Sustained upward revisions show that the sell-side expects further outperformance, and the average price target implies nearly double upside from current price. While dispersion signals uncertainty, the magnitude and direction of consensus revisions provide a strong forward-looking tailwind.

---

---

BEAR COUNTER-ARGUMENTS

---

Bear said: “Share dilution: Shares increased 21.5% (159m → 193m) in 3 years, meaningfully diluting per-share value.”
Counter: *EPS still grew +108.6% YoY, FCF $812M, and Next-12mo EPS revised up 8.7% in last 90d*—despite dilution, per-share earnings are increasing faster than share count. Dilution risk is real, but operational outperformance offsets (and then some) for now. Conviction: MEDIUM; dilution remains a concern if future growth slows.

---

Bear said: “Beta/Volatility: Beta >2.2, outsized swings, crash profile proved.”
Counter: *Current ratio 10.8, Debt/Equity 0.88, FCF $812M*—core business is stable and liquid, reducing risk of distress even under volatility. High beta is a risk to realized returns, but underlying quality supports resilience. Conviction: MEDIUM; volatility is only attractive for tactical trades or with risk-managed sizing.

---

Bear said: “No dividend.”
Counter: *EPS growth +108.6% YoY, revenue +53.6% YoY, FCF $812M*—capital is being reinvested for growth at high returns (ROE 32%), supporting long-term compounding better than a low-yield dividend would. Conviction: HIGH; growth profile outweighs lack of yield.

---

Bear said: “Analyst dispersion: Price target high/low spread at 97.7% of average target = very low consensus/conviction, signaling high forecast uncertainty.”
Counter: *Estimate revisions are up +8.7% (90d), four straight EPS beats (+33.1%, +79.1%, +29.6%, +5.6%)*—actual results are beating expectations, reducing forecast uncertainty over time. Dispersion remains a legitimate risk, but directionally the consensus is moving higher. Conviction: MEDIUM; forecast uncertainty is a valid caution, but quality of earnings surprises offsets.

---

Bear said: “Price/Book >4: Growth premium—may compress in risk-off/rate hike environment.”
Counter: *Forward P/E 9.8x, PEG 0.46; Net margin 32.1%*—valuation multiples are attractive despite price/book, and current profitability offsets risk of re-rating unless fundamentals deteriorate. Conviction: HIGH; price/book is only concerning in absence of earnings/future growth.

---

---

BULL THESIS INVALIDATION LEVEL

- The bull thesis breaks if:
- Next quarter shows *revenue growth <10% YoY* OR *EPS misses consensus by >15%*.
- *Fails to reclaim $115.51* (lower Bollinger Band) within 14 trading days—no mean reversion signal confirmed.
- *Estimate revisions turn negative* (downward EPS guidance).
- *Liquidity/solvency deteriorates* (current ratio <5, debt/equity >1.5).

---

OVERALL BULL CONVICTION: MEDIUM (6/10)

- Justification:
- Three HIGH conviction arguments (valuation, profitability, growth) are supported by clear, strong fundamental numbers.
- Two MEDIUM conviction arguments (mean reversion setup, estimate momentum) rely on oversold technicals and forward-looking revision trends but are diminished by quant/technical regime conflict, volatile options, and lack of peer benchmarks.
- Fundamental evidence quality is high, but recent technical crash, extreme volatility, regime conflict, dilution risk, and low consensus reduce certainty.
- Bull thesis relies on continued growth and profitability outpacing dilution and volatility; if these break, conviction drops quickly.

---

Summary:
RDDT offers a rare combination of deep value (low forward P/E, PEG) and top-quartile growth/profitability metrics, confirmed by estimate momentum and repeated earnings beats. Tactical mean-reversion setup is attractive, but regime alignment is poor and volatility is extreme; prudent position sizing, strict risk management, and reversal confirmation are mandatory. Dilution and uncertainty are risks but currently outweighed by strong operational execution. If fundamentals degrade or reversal fails, the bull case is invalidated.
Bear Analyst: BEAR CASE RISKS

---

Risk 1 – Technical/Quant Breakdown [HIGH conviction]
Evidence: Price $91.73 is 42.4% below 200MA ($159.37), 39% below 50MA ($150.37); Technical Score 1.9/10; Quant composite -34.7/100 (conviction 3.6/10); Momentum signals: tsmom_12_1 -82, drawdown_trend -100, kalman_slope -4.68; Realized volatility (20d): 128.3%; Max drawdown (1y): -64.6%.
Risk: Severe price dislocation confirms maximum trend breakdown. High volatility amplifies further downside potential, especially since mean-reversion signals lack confirmation from price action.
Quantified downside: If breakdown persists (e.g., fails to reclaim $115.51, lower Bollinger Band), downside risk is -15% to -25% (to retest/pierce recent panic low $89.28 or ATR move to $81).

---

Risk 2 – Share Dilution/Fundamental De-rating [MEDIUM conviction]
Evidence: Share count up 21.5% in 3 years (159m → 193m); Insider sales last 90 days: $26.8M (no purchases); Analyst price targets dispersion: 97.7% spread of mean (low consensus).
Risk: Dilution reduces per-share value; insider selling and wide target dispersion signal uncertainty and potential for future further dilution or lower EPS growth. If operational outperformance slows, dilution will rapidly erode per-share metrics.
Quantified downside: If EPS growth slows to <10% YoY and further shares are issued, downside of 20–30% (move below recent lows, price/book compresses to sector average).

---

Risk 3 – Beta/Volatility Exposure [MEDIUM conviction]
Evidence: Beta = 2.28, Sharpe (126d): -1.37, Sortino: -1.59; Daily VaR 95%: -7.19%, CVaR 95%: -11.02%; ATR = 9.91 (10.8% of price).
Risk: Extreme volatility and high beta expose the stock to outsized swings. Left-tail risk in Monte Carlo simulation is -27.1% (5th percentile over 21d).
Quantified downside: Materializes as additional 10–30% drawdowns in single 1–2 week windows; risk compounds if negative trend persists.

---

Risk 4 – Estimate/Forecast Uncertainty [MEDIUM conviction]
Evidence: Analyst price target average $165.8, but high/low spread $272/$110 = 97.7% of mean; Next-12mo EPS revised up 8.7% (positive), but regime conflict (Quant & Technical both bear, Monte Carlo risk band -27% to +43%).
Risk: Forecast uncertainty is extreme despite recent estimate momentum. If consensus turns negative, stock could re-rate sharply downward.
Quantified downside: A consensus estimate cut or earnings miss (>15% below) likely triggers 15–25% downside, based on historical reactions and peer group mean reversion levels.

---

Risk 5 – Relative Value Uncertainty [LOW conviction]
Evidence: No peer data for margins/valuation, Price/book 4.95x, risk of compression in risk-off/rate hike scenario.
Risk: Without peer comparison, “deep value” status is unverified. If peers trade at much lower multiples, sector mean reversion could force price/book down to <3x, which implies abrupt de-rating.
Quantified downside: If compression to sector mean occurs, could see 15–20% further downside.

---

---

BULL COUNTER-ARGUMENTS

---

Bull said: “Forward P/E 9.82x, PEG 0.46, EPS estimates up +8.7%, four EPS beats.”
Counter: Technical/Quant regime is overwhelmingly negative (Trend Score 1/10, momentum tsmom_12_1 -82, drawdown_trend -100). Price is 42% below 200MA and -64.6% off recent highs. Historically, “deep value” multiples often signal a value trap when accompanied by technical collapse and regime conflict—not genuine upside. Until price stabilizes and mean-reversion is confirmed, multiples can compress sharply further.

---

Bull said: “Profitability/Balance Sheet: Net margin 32.1%, ROE 32%, FCF $812M, Current ratio 10.8, Debt/Equity 0.88.”
Counter: Share count is up 21.5% in 3 years, insider sales last 90 days are $26.8M (no buys). Wide analyst dispersion (97.7% of target mean) undermines conviction in continued margin quality. If capital allocation deteriorates or growth slows, dilution will erode returns even with strong margins.

---

Bull said: “EPS +108.6% YoY, Revenue +53.6% YoY.”
Counter: Growth rates are backward-looking and may reflect one-time/low-base effects (not persistent). If the next quarter lands below 10% YoY revenue growth or misses EPS consensus by >15%, the market may rapidly de-rate (“bull thesis break” level). Historically, stocks in technical crash with high volatility often see forward estimates re-rated downward.

---

Bull said: “Mean Reversion Setup: RSI 17.45, MACD Histogram -5.05, breakdown below lower Bollinger.”
Counter: Quant/momentum signals dominate in high-vol, trending regime (vol_regime -90, ma_trend -99, rel_strength -100, drawdown_trend -100), so mean-reversion is low conviction unless reversal is confirmed. Probability-weighted risk band (-27% to +43%) shows massive left-tail risk. Only price recovery above $115.51 would justify optimism; until then, further panic is base case.

---

Bull said: “Estimate Momentum/Catalyst: EPS revised up +8.7%, analyst average target +80.8% upside.”
Counter: Analyst targets are highly dispersed (spread = 97.7% of mean); insiders are net sellers; quant/technical regime is bear, mean-reversion signals may be noise. Even with estimate revision, regime conflict means forecast uncertainty and technical breakdown outweigh analyst optimism.

---

---

RED FLAGS FROM ANALYST REPORTS

- Share dilution: Shares up 21.5% in three years (159m → 193m).
- Insider selling: $26.8M in last 90 days; no insider buys.
- Beta: 2.28 (extraordinary volatility, outsized swings).
- Technical collapse: Price 42.4% below 200MA, below lower Bollinger Band, no support held.
- Max drawdown: -64.6% over past year.
- Analyst price target dispersion: 97.7% of mean; extremely low consensus.
- No sector peer data: Fundamental “deep value” cannot be proven relative to sector/similar companies.

---

BEAR THESIS CONFIRMATION SIGNAL

Bear thesis accelerates if:
- Price fails to reclaim $115.51 (lower Bollinger Band) within 14 trading days (technical breakdown persists)
- Next quarter revenue growth <10% YoY or EPS misses consensus by >15%
- Estimate revisions turn negative
- Further insider selling or increased dilution
- Stock breaches support at $89.28 (recent panic low) or stop-loss $87.50 (accelerated breakdown)

---

OVERALL BEAR CONVICTION: HIGH (8/10)

Justification:
- Multiple HIGH conviction risk signals: price/quant technical breakdown (trend, momentum, volatility) dominate across all models.
- Share dilution and insider selling are clear red flags, compounded by extreme analyst uncertainty and lack of peer valuation context.
- Macro regime is bullish, but RDDT is a sector laggard and in a technical waterfall. Reversal/momentum signals lack confirmation and are outweighed by regime/trend signals.
- While fundamentals remain positive, they are backward-looking and subject to collapse in a breakdown environment; confirmation triggers are all at risk of failure.
- Downside risk quantified at 15–30%, with left-tail scenario up to -64% drawdown.

Unless technical reversal confirms and estimate momentum persists, the bear thesis is strongly supported and prevailing.

Want a fresh check?

A new AI check reads today's prices, news and filings. Compact check: one per month free with an account, ready in a few minutes. Full check with every analyst and chart technicals: in a plan or €3.99 once, about 10 minutes.

Start a new AI checkCheck your own entry (free)

Kairon's record on RDDT

1 past checks: 1 directional calls (0 right, 1 wrong). Measured by price since each check, no costs. How we measure. Every 'not now' answer.

Nov 2, 2026: Long at $91.73, −7.0 % sincewrong

Insider and Congress filings

Loading…

Official SEC Form 4 and House PTR filings. Returns run from the first close after a filing became public. A filing is a fact, not a recommendation.

Full report (technical terms)

Key levels

Quant score-35/100

AI-generated. Created 2026-11-02 13:16 UTC automatically by Kairon AI (Cem Salomon Weidner, Vienna, Austria) at a price of $91.73. Valid for its time frame from that moment; it is not updated afterwards. Facts come from public sources (Yahoo Finance and others, partly delayed); the rating, levels and scenarios are opinions of the AI. General information, not investment advice and not a solicitation to buy or sell. Conflicts of interest, methodology and risks: disclosure. Every past call and its outcome: track record.

Open this analysis in the app

More checks

Learn the method

Kairon AI is an automated research and second-opinion tool, not a licensed financial advisor, broker, or investment manager. All assessments are AI-generated opinions based on public data and are informational only — not personal investment advice. Investing carries risk, including total loss of capital.

Impressum Privacy Terms Disclaimer